LPAAU

Launch One Acquisition Corp.

• PUBT·05/14 21:16

  Launch One net income falls 25.68% to $1.7 million in Q1 FY26

• Reuters·03/26 20:06

  Launch One Acquisition enters working capital note with Launch One Sponsor; loan capacity rises to $1.0 million

• Reuters·02/04 11:12

  LAUNCH ONE ACQUISITION CORP: PARTIES MUTUALLY AGREED TO TERMINATE BUSINESS COMBINATION AGREEMENT

• Reuters·02/04 11:12

  LAUNCH ONE ACQUISITION CORP: AS OF JAN 30, CO, SPAC REPRESENTATIVE, MINOVIA, SELLER REPRESENTATIVE ENTERED INTO TERMINATION AND RELEASE AGREEMENT

• Reuters·01/13 14:52

  Minovia Therapeutics to Merge with Launch One Acquisition Corp. and List on Nasdaq

• Reuters·01/13 14:51

  MINOVIA THERAPEUTICS ANNOUNCES TWO NEW U.S. PATENTS GRANTED, STRENGTHENING ITS MITOCHONDRIAL AUGMENTATION THERAPY PLATFORM

• Reuters·10/15/2025 11:30

  MINOVIA THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR MNV-201 IN MYELODYSPLASTIC SYNDROME

• Reuters·07/24/2025 12:15

  MINOVIA THERAPEUTICS ANNOUNCES INTERIM DATA FROM PHASE 2 TRIAL IN PEARSON SYNDROME DEMONSTRATING NO TREATMENT-RELATED SERIOUS ADVERSE EVENTS AND PRELIMINARY SIGNAL FOR EFFICACY MEASURED BY GROWTH

• Reuters·06/30/2025 12:30

  MINOVIA THERAPEUTICS ANNOUNCES FDA FAST TRACK AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR MNV-201 IN PEARSON SYNDROME

• Reuters·06/25/2025 12:30

  MINOVIA THERAPEUTICS - UNDER DEAL, CO ASSIGNED PRE-MONEY EQUITY VALUATION OF $180 MLN